RARE Stock Analysis Overview
What this means: Ultragenyx Pharmaceu (RARE) gets an Overall Rank of 64, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. RARE's 64 means that it ranks higher than 64% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
RARE Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
RARE Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
RARE Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
RARE Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
RARE Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
RARE Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
RARE Stock Analysis Overview
What this means: Ultragenyx Pharmaceu (RARE) gets an Overall Rank of 64, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. RARE's 64 means that it ranks higher than 64% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.